CIK 0001434316
- Non-accelerated filer
- Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 651311552
- Phone
- +1 858-875-1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-12 | Jooss Karin Director | Grant or award · Stock Option (Right to Buy) | +87,900 | 87,900 | ||
| 2025-05-29 | Jooss Karin Director | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2024-06-07 | Jooss Karin Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2023-06-06 | Jooss Karin Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-06-09 | Jooss Karin Director | Grant or award | +8,650 | 9,848 | ||
| 2022-06-09 | Jooss Karin Director | Grant or award · Stock Option (Right to Buy) | +11,893 | 11,893 | ||
| 2022-06-03 | Jooss Karin Director | Sale | −1,483 | $22.82 | $34K | 1,198 |
| 2021-06-02 | Jooss Karin Director | Grant or award | +2,681 | 2,681 | ||
| 2021-06-02 | Jooss Karin Director | Grant or award · Stock Option (Right to Buy) | +4,334 | 4,334 | ||
| 2020-05-01 | Jooss Karin Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2019-05-03 | Jooss Karin Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2019-03-14 | Jooss Karin Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 |
Page 1 of 1 · 12 trades